153 related articles for article (PubMed ID: 28101198)
1. Elevated expression of Nrf2 mediates multidrug resistance in CD133
Lu BC; Li J; Yu WF; Zhang GZ; Wang HM; Ma HM
Oncol Lett; 2016 Dec; 12(6):4333-4338. PubMed ID: 28101198
[TBL] [Abstract][Full Text] [Related]
2. Significance of ATP-binding cassette transporter proteins in multidrug resistance of head and neck squamous cell carcinoma.
Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
Oncol Lett; 2015 Aug; 10(2):631-636. PubMed ID: 26622545
[TBL] [Abstract][Full Text] [Related]
3. Elevated Expression of Nrf-2 and ABCG2 Involved in Multi-drug Resistance of Lung Cancer SP Cells.
Yang B; Ma YF; Liu Y
Drug Res (Stuttg); 2015 Oct; 65(10):526-31. PubMed ID: 25368906
[TBL] [Abstract][Full Text] [Related]
4. Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma.
Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
Mol Med Rep; 2015 Sep; 12(3):4352-4357. PubMed ID: 26081022
[TBL] [Abstract][Full Text] [Related]
5. Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes.
Jia Y; Chen J; Zhu H; Jia ZH; Cui MH
Oncol Rep; 2015 Nov; 34(5):2296-304. PubMed ID: 26324021
[TBL] [Abstract][Full Text] [Related]
6. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
7. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
Xie ZY; Lv K; Xiong Y; Guo WH
Oncol Res Treat; 2014; 37(11):666-8, 670-2. PubMed ID: 25427584
[TBL] [Abstract][Full Text] [Related]
8. ABCG2 expression is correlated neither to side population nor to hematopoietic progenitor function in human umbilical cord blood.
Alt R; Wilhelm F; Pelz-Ackermann O; Egger D; Niederwieser D; Cross M
Exp Hematol; 2009 Feb; 37(2):294-301. PubMed ID: 19101070
[TBL] [Abstract][Full Text] [Related]
9. Constitutive secretion of Interleukin-4 dictates CD133+ side population cells to resist drug treatment and cell death.
Guan GF; Tang XX; Zhang DJ; Zheng Y; Yu DJ; Zhao Y; Lu YQ; Zhu L
J BUON; 2015; 20(5):1350-9. PubMed ID: 26537085
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of ABCG2 in head and neck squamous cell carcinoma and cell lines.
Shen B; Dong P; Li D; Gao S
Exp Ther Med; 2011 Nov; 2(6):1151-1157. PubMed ID: 22977636
[TBL] [Abstract][Full Text] [Related]
11. Role of CD133/NRF2 Axis in the Development of Colon Cancer Stem Cell-Like Properties.
Park J; Kim SK; Hallis SP; Choi BH; Kwak MK
Front Oncol; 2021; 11():808300. PubMed ID: 35155201
[TBL] [Abstract][Full Text] [Related]
12. Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.
Zhang QH; Dou HT; Xu P; Zhuang SC; Liu PS
Drug Res (Stuttg); 2015 Mar; 65(3):153-7. PubMed ID: 25504004
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a side population of astrocytoma cells in response to temozolomide.
Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C
J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075
[TBL] [Abstract][Full Text] [Related]
14. ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells.
Murakami K; Umemura N; Adachi M; Motoki M; Ohkoshi E
Exp Ther Med; 2022 Dec; 24(6):722. PubMed ID: 36340608
[TBL] [Abstract][Full Text] [Related]
15. Biologic characteristics of the side population of human small cell lung cancer cell line H446.
Wang B; Yang H; Huang YZ; Yan RH; Liu FJ; Zhang JN
Chin J Cancer; 2010 Mar; 29(3):254-60. PubMed ID: 20193106
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
[TBL] [Abstract][Full Text] [Related]
17. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
[TBL] [Abstract][Full Text] [Related]
18. EGFR regulates the side population in head and neck squamous cell carcinoma.
Chen JS; Pardo FS; Wang-Rodriguez J; Chu TS; Lopez JP; Aguilera J; Altuna X; Weisman RA; Ongkeko WM
Laryngoscope; 2006 Mar; 116(3):401-6. PubMed ID: 16540898
[TBL] [Abstract][Full Text] [Related]
19. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck.
Okamoto A; Chikamatsu K; Sakakura K; Hatsushika K; Takahashi G; Masuyama K
Oral Oncol; 2009 Jul; 45(7):633-9. PubMed ID: 19027347
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas.
Lim YC; Oh SY; Cha YY; Kim SH; Jin X; Kim H
Oral Oncol; 2011 Feb; 47(2):83-91. PubMed ID: 21167769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
